Art. 3 Directive (EU) 1989/105

In forcesince 21 Dec 1988cited 14×

Without prejudice to Article 4, the following provisions shall apply if an increase in the price of a medicinal product is permitted only after prior approval has been obtained from the competent authorities:

1.

Member States shall ensure that a decision is adopted on an application submitted, in accordance with the requirements laid down in the Member State concerned, by the holder of a marketing authorization to increase the price of a medicinal product and communicated to the applicant within 90 days of its receipt. The applicant shall furnish the competent authorities with adequate information including details of those events intervening since the price of the medicinal product was last determined which in his opinion justify the price increase requested. If the information supporting the application is inadequate, the competent authorities shall forthwith notify the applicant of what detailed additional information is required and take their final decision within 90 days of receipt of this additional information.

In case of an exceptional number of applications, the period may be extended once only for a further 60 days. The applicant shall be notified of such extension before the expiry of the period.

In the absence of such a decision within the abovementioned period or periods, the applicant shall be entitled to apply in full the price increase requested.

2.

Should the competent authorities decide not to permit the whole or part of the price increase requested, the decision shall contain a statement of reasons based on objective and verifiable criteria and the applicant shall be informed of the remedies available to him under the laws in force and the time limits allowed for applying for such remedies.

3.

At least once a year, the competent authorities shall publish in an appropriate publication and communicate to the Commission, a list of the medicinal products for which price increases have been granted during the relevant period, together with the new price which may be charged for such products.

The 10 that are cited most themselves, of 14.

  • Judgment of the Court (Seventh Chamber) of 22 December 2022. Syndicat Les Entreprises du Médicament (LEEM) v Ministre des Solidarités et de Decision

    In that regard, Articles 2 and 3 of that directive, which concern, respectively, situations in which approval of the price of a medicinal product is required before it is marketed and situations in which an increase in the price of a …

    22 Dec 2022 · 62022CJ0020

  • Judgment of the Court (First Chamber) of 21 November 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and Others.Decision

    … Лекарствени продукти за хуманна употреба Директива 2001/83/ЕО Член 3, точка 1 Член 6 Директива 89/105/ЕИО Регламент (ЕО) № 726/2004 Членове 3, 25 …

    21 Nov 2018 · 62017CJ0029

  • BSG, Urteil vom 3. Mai 2018 - B 3 KR 7/17 RDecision

    3 May 2018 · KSRE147820218

  • Conseil d'État, 1ère et 6ème sous-sections réunies, 24/09/2010, 334125Decision

    … et le comité économique des produits de santé ou, à défaut, par décision du comité (...) ; qu'aux termes de l'article 3 de la directive 89/105/CEE du Conseil du 21 décembre 1988 : (...) 2. Lorsque les autorités compétentes …

    24 Sep 2010 · CETATEXT000022859541

  • Opinion of Mr Advocate General Jääskinen delivered on 11 February 2010. The Queen, on the application of Association of the British PharmaceDecision

    … например член 3, параграфи 1 и 2 от Директива 89/105.]. В съответствие с процедурите по Директива 89/105 държавата членка също така е …

    11 Feb 2010 · 62009CC0062

  • Opinion of Advocate General Trstenjak delivered on 13 November 2008. A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero Decision

    … компетентния орган по заявления за одобряване на цени съгласно членове 2 и 3 от Директива 89/105 цената или нейното увеличение …

    13 Nov 2008 · 62007CC0352

  • Conseil d'État, 1ère chambre jugeant seule, 27 juin 2024, n° 449049, inédit au recueil LebonDecision

    … de l'article 34 du traité sur le fonctionnement de l'Union européenne, du principe de non-discrimination et des articles 1, 2, 3 et 11 de la directive 89/105/CEE du Conseil, du 21 décembre 1988, concernant la transparence des mesures …

    27 Jun 2024 · DCE_449049_20240627

  • Conseil d'État, 1ère chambre, 27/06/2024, 449049, Inédit au recueil LebonDecision

    27 Jun 2024 · CETATEXT000049823551

  • Conseil d'État, 1ère chambre, 06/07/2023, 463902, Inédit au recueil LebonDecision

    6 Jul 2023 · CETATEXT000047799220

  • Conseil d'État, 1ère chambre jugeant seule, 6 juillet 2023, n° 463902, inédit au recueil LebonDecision

    … Aux termes de l'article 3 de la directive 89/105/CEE du Conseil du 21 décembre 1988 concernant la transparence des mesures régissant la fixation des prix des médicaments à usage humain et leur inclusion dans le champ d'application des …

    6 Jul 2023 · DCE_463902_20230706